|1.||Macular Degeneration (Age-Related Maculopathy)
|1.||Campochiaro, Peter A: 42 articles (01/2015 - 04/2002)|
|2.||Bressler, Neil M: 35 articles (01/2015 - 01/2002)|
|3.||Bandello, Francesco: 33 articles (01/2016 - 06/2002)|
|4.||Spaide, Richard F: 28 articles (12/2015 - 02/2002)|
|5.||Miller, Joan W: 28 articles (07/2012 - 03/2002)|
|6.||Schmidt-Erfurth, Ursula: 25 articles (12/2013 - 03/2002)|
|7.||Freund, K Bailey: 24 articles (02/2015 - 02/2002)|
|8.||Kaiser, Peter K: 23 articles (01/2016 - 03/2005)|
|9.||Souied, Eric H: 23 articles (11/2015 - 08/2005)|
|10.||Slakter, Jason S: 23 articles (01/2015 - 02/2002)|
|1.||ranibizumab (Lucentis)FDA Link
05/01/2012 - "We report the first case of choroidal neovascularization associated with Strüpell-Lorrain syndrome treated successfully with intravitreal ranibizumab injection."
10/01/2010 - "The role of ranibizumab in choroidal neovascularization in association with punctate inner choroidopathy has been shown to be beneficial in this small group in whom improvement or stabilization of vision was observed in 9 of 10 eyes. "
09/01/2012 - "Intravitreal ranibizumab and IVB are effective in the treatment of subfoveal myopic choroidal neovascularization. "
05/01/2012 - "Intravitreal ranibizumab may be effective to induce morphological and functional improvement in cases of choroidal neovascularization secondary to adult-onset vitelliform foveomacular dystrophy. "
01/01/2012 - "Intravitreal ranibizumab seems to be an effective and safe option for the treatment of subfoveal choroidal neovascularization in patients with butterfly-shaped PD."
01/01/2011 - "Intravitreal bevacizumab was well tolerated, choroidal neovascularization involuted, and best-corrected visual acuity improved to 20/32. "
03/01/2011 - "Intravitreal bevacizumab has proven to be an effective treatment for choroidal neovascularization and shows a significant improvement of vision for wet AMD patients. "
01/01/2014 - "To evaluate the safety and efficacy of intravitreal bevacizumab (IVB) in the treatment of high myopic choroidal neovascularization (CNV). "
01/01/2012 - "Only first intravitreal bevacizumab injection achieves statistically significant visual improvement in naïve myopic choroidal neovascularization."
01/01/2013 - "The purpose of this study was to evaluate the efficacy and safety of bevacizumab in the first-line treatment of myopic choroidal neovascularization. "
09/01/2007 - "PDT i s indicated in theclassical or predominantly classical choroid neovascularization (CNV), anti-VEFG drugs are effective in all forms of exsudative AMD. "
01/01/2007 - "PDT seems to be effective for treating the choroidal neovascularization complicating PDT performed for CSC."
06/01/2006 - "Low power TTT is as effective as standard power in stabilizing or improving vision and reducing overlying exudation in patients with active subfoveal choroidal neovascularization ineligible for PDT."
06/01/2005 - "Although PDT is effective in closing the choroidal neovascularization in FVT, this technique was ineffective in occluding anastomotic vessels and their associated tributaries within the mid- to proximal retina. "
05/01/2003 - "PDT shows efficacy for classic choroidal neovascularization beyond the common indication."
|4.||verteporfin (Visudyne)FDA Link
12/01/2007 - "Verteporfin therapy of subfoveal occult choroidal neovascularization in AMD using delayed light application: one-year results of the VALIO Study."
05/01/2001 - "Other secondary outcomes, including visual acuity letter score worse than 34 (approximate Snellen equivalent of 20/200 or worse), mean change in visual acuity letter score, development of classic choroidal neovascularization, progression of classic choroidal neovascularization and size of lesion, favored the verteporfin-treated group at both the month 12 and month 24 examination for both the entire study group and the subgroup of cases with occult with no classic choroidal neovascularization at baseline. "
07/01/2007 - "More over the quality assurance regulations for the photodynamic treatment of choroidal neovascularizations with Verteporfin were modified including the treatment of occult lesions and implementing a simplified classification of extra- and subfoveal lesions. "
01/01/2006 - "Nineteen consecutive patients with predominantly classic choroidal neovascularization (CNV) in AMD were treated with 6 mg/m2 verteporfin given as bolus infusion. "
12/01/2005 - "To evaluate the time course and morphologic features of verteporfin therapy-induced vascular effects using 3-dimensional topographic angiography (TAG) in patients with choroidal neovascularization (CNV). "
|5.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/01/2014 - "Anti-VEGF therapy is the effective treatment of idiopathic choroidal neovascularization in the described case. "
07/01/2012 - "To evaluate the long-term efficacy of intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy as primary treatment for subfoveal myopic choroidal neovascularization (CNV). "
10/01/2015 - "To study the effect of anti-vascular endothelial growth factor (VEGF) therapy on subretinal hyperreflective exudation detected by spectral-domain optical coherence tomography (SD OCT) in myopic choroidal neovascularization (CNV). "
09/01/2015 - "This 12-month, randomized, multicentre, open-label study enrolled patients aged ≥ 50 years with choroidal neovascularization (CNV) secondary to AMD who had not received anti-VEGF agents. "
05/01/2015 - "Vascular endothelial growth factor-A has been implicated as the major angiogenic stimulus responsible for choroidal neovascularization secondary to AMD and several major studies have proved the benefits of anti-VEGF treatment for AMD-related CNVM. "
09/01/2007 - "Six eyes from six patients who developed RPE tears while undergoing treatment with pegaptanib for AMD-related fibrovascular pigment epithelial detachment (PED) and occult choroidal neovascularization (CNV) were identified retrospectively. "
06/01/2007 - "Pegaptanib for myopic choroidal neovascularization in a young patient."
10/01/2006 - "Within six weeks of an intravitreal pegaptanib injection, the choroidal neovascularization (CNV) progressed. "
09/01/2013 - "Of Japanese neovascular AMD patients with choroidal neovascularization who showed improvement in visual acuity (VA) with induction therapy, those who were scheduled for intravitreal injections of pegaptanib as maintenance therapy were recruited. "
07/01/2006 - "To report two cases of retinal pigment epithelium (RPE) tears following intravitreal pegaptanib injections for occult choroidal neovascularization. "
|7.||Fluorescein (Funduscein)FDA LinkGeneric
01/01/2011 - "In this case described combined pharmacological-surgical therapy allowed a significant improvement in visual acuity and closure of choroidal neovascularization (CNV), leakage confirmed by fluorescein angiography (FA) and optical coherence tomography (AMD). "
01/01/2014 - "The observational case series study included patients who were consecutively diagnosed with idiopathic unilateral choroidal neovascularization as demonstrated by ophthalmoscopy, fluorescein angiography and enhanced depth imaging optical coherence tomography (EDI-OCT). "
01/01/2014 - "The purpose of this study was to develop a non-biased method of quantitatively measuring choroidal neovascularization (CNV) areas based on late-phase fluorescein angiography (FA) images. "
12/01/2006 - "In this study, the authors sought to develop and characterize techniques for measuring changes in choroidal neovascularization (CNV) lesion size and fluorescence over time for quantitative analysis of fluorescein angiograms. "
02/01/2006 - "To compare topographic features of surgically excised subfoveal choroidal neovascularization with preoperative and postoperative fluorescein angiographic features from Submacular Surgery Trials (SST) patients, and to compare histological and angiographic features with preoperative and postoperative visual acuities (VAs). "
01/20/2003 - "Periocular delivery offers potential advantages over other routes of delivery and the demonstration that sFlt-1 enters the eye from the periocular space in sufficient levels to achieve efficacy in treating choroidal neovascularization and retinal vascular permeability is a novel finding that has important clinical implications. "
11/01/2011 - "This prospective, randomized, but unblinded trial revealed a significant improvement in vision with both treatments in terms of visual acuity; importantly, patients with juxtafoveal choroidal neovascularization (CNV) and retinal pigment epithelial detachments were not excluded from the study. "
05/01/1993 - "These data suggest that retinal pigmented epithelial cells may help to alter proteolytic activity in the subretinal space and thereby participate, along with endothelial cells, in the regulation of choroidal neovascularization."
01/01/2009 - "In this study, we used a humanized monoclonal antibody (sonepcizumab) that selectively binds S1P to investigate its role in retinal and choroidal neovascularization (NV). "
11/01/2006 - "Bilateral midperipheral large drusen and retinal pigment epithelial detachments associated with multifocal areas of choroidal neovascularization: a histopathologic study."
|9.||Indocyanine Green (Cardio-Green)FDA LinkGeneric
12/01/2014 - "To evaluate the efficacy of spectral-domain optical coherence tomography (SD OCT) compared to indocyanine green angiography (ICGA) in detecting idiopathic polypoidal choroidal vasculopathy (PCV) and in differentiating between PCV and occult choroidal neovascularization (CNV). "
03/01/2000 - "This study aimed to determine whether indocyanine green (ICG) angiography is useful to identify the ingrowth site of idiopathic choroidal neovascularization (CNV), which can predict visual outcomes after surgical removal of idiopathic CNV. "
09/01/1998 - "Recent studies have shown that indocyanine-green videoangiography (ICG-V) is useful to image occult choroidal neovascularization. "
04/01/1998 - "This study aimed to use a new technique for ocular imaging, digital subtraction indocyanine green angiography (DS-ICGA), to evaluate patients with occult choroidal neovascularization (CNV). "
03/01/1995 - "Several studies have shown that indocyanine green (ICG) angiography improves the detection of occult choroidal neovascularization (CNV). "
08/01/2009 - "Intravitreal pegabtanib sodium in choroidal neovascularization secondary to angioid streaks."
02/01/2013 - "Intravitreal pegaptanib sodium (Macugen) for treatment of myopic choroidal neovascularization: a morphologic and functional study."
09/01/2007 - "In the combined cohorts, 147 subjects with any angiographic subtype of subfoveal choroidal neovascularization secondary to AMD and best-corrected visual acuities (VAs) in the study eye of 20/40 to 20/320 and in the fellow eye of 20/800 or better received pegaptanib sodium. "
04/01/2013 - "To evaluate ophthalmologic outcomes 1 year after intravitreal pegaptanib sodium injection in patients with myopic choroidal neovascularization (CNV). "
04/01/2013 - "[Intravitreal pegaptanib sodium for myopic choroidal neovascularization: 1 year results of a prospective pilot study]."
|1.||Photochemotherapy (Photodynamic Therapy)
11/01/2007 - "Today photodynamic therapy is an effective treatment of subfoveal choroidal neovascularization. "
08/01/2002 - "Photodynamic therapy is a promising treatment modality shown to be effective in achieving closure and stabilization of vision loss compared with placebo control in eyes with subfoveal choroidal neovascularization."
08/01/2002 - "Photodynamic therapy has been shown to be effective in closing both experimental choroidal neovascularization in animal models as well as subfoveal choroidal neovascularization in humans. "
01/01/2007 - "Efficacy of photodynamic therapy in the management of occult choroidal neovascularization associated with serous pigment epithelium detachment."
06/01/2005 - "Intense efforts oriented toward defining the most beneficial therapeutic modality have resulted in some well-designed, large studies that evaluated submacular surgery, photodynamic therapies, and anti-angiogenic therapies, as well as small pilot studies exploring new therapeutic approaches for choroidal neovascularization. "
10/01/2002 - "However, it remains to be determined whether laser-induced drusen reduction is beneficial for visual acuity or reduces the incidence of choroidal neovascularization (CNV) in eyes with nonexudative ARMD."
10/01/2000 - "Both wild type and transgenic mice developed choroidal neovascularization in areas of intense laser that ruptured Bruch's membrane, but the area of neovascularization was significantly greater in transgenics. "
10/01/2015 - "Therapeutic efficacy is routinely assessed by measurement of lesion size using flatmounted choroids and confocal microscopy in the laser-induced choroidal neovascularization (L-CNV) rodent model. "
03/01/2006 - "The densitometry method proved effective for calculating the extent of laser induced choroidal neovascularization. "
02/01/2013 - "To evaluate the efficacy of a novel CCR3 antagonist for laser injury-induced choroidal neovascularization (CNV) in mice. "
04/30/2015 - "Also, iVR1 impressively inhibited choroid neovascularization after a single intravitreal injection. "
05/01/2013 - "Forty-eight eyes of 24 patients undergoing serial unilateral intravitreal injection for choroidal neovascularization. "
10/01/2012 - "Proband had a multifocal type pattern dystrophy, and his choroidal neovascularization regressed after four intravitreal injections. "
10/01/2012 - "The proband presented with choroidal neovascularization and had intravitreal injections as needed according to visual acuity and optical coherence tomography. "
04/01/2012 - "An approach based on clinical onset and choroidal neovascularization progression at angiography may provide benefit by reducing the number of intravitreal injections required."
07/01/2000 - "Data from patients eligible for treatment of subfoveal choroidal neovascularization obtained by researchers in the Macular Photocoagulation Study were used for the analysis. "
01/01/1995 - "Treatment of choroidal neovascularization: updated information from recent macular photocoagulation study group reports."
05/01/1977 - "Randomized controlled studies are required to document the role of photocoagulation therapy for choroidal neovascularization."
08/01/2012 - "Fundus fluorescence angiography, histopathology, immunohistochemistry and quantitative analysis of choroidal neovascularization (CNV) were performed 3 weeks after photocoagulation. "
06/01/2002 - "When choroidal neovascularization was induced, highly effective transfection of the decoy was observed 3 to 14 days after photocoagulation, after which the level decreased. "
01/01/2012 - "After accounting for age, sex, size of choroidal neovascularization, and number of injections, patients who deteriorated in visual acuity at 12 months had significantly larger baseline CRVE, 243.10 μm (95% confidence interval [CI], 227.01-259.19), compared with those who were stable, 214.30 μm (95% CI, 205.79-222.81) and those who improved, 215.26 μm (95% CI, 204.69-225.84; P = 0.007). "
12/01/2012 - "The FUSION regimen consists of three phases: 1) a loading phase of two or three injections, depending on presence or absence of choroidal neovascularization activity at first follow-up, 2) administration of one injection on disappearance of exudation, and 3) subsequent administration of two separate injections at intervals 2 months apart, and then an injection every 3 months. "
10/01/2011 - "Forty-eight eyes of 24 patients undergoing serial unilateral intravitreal (IVT) injections for choroidal neovascularization. "
05/01/2011 - "Compared with 3 monthly injections followed by PRN, single injection followed by PRN for myopic choroidal neovascularization required fewer injections and produced a similar visual outcome over 12 months."
01/01/2011 - "Although the patient was young several injections were necessary before the choroidal neovascularization vanished."